Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity

This study has been completed.
Information provided by:
Università degli Studi dell'Insubria Identifier:
First received: October 27, 2009
Last updated: NA
Last verified: October 2009
History: No changes posted

In the last decade, several authors proposed ultrasound measurement of Bladder wall thickness (BWT) for the screening of the voiding dysfunction and of the detrusor overactivity (DO). The aims of the investigator prospective study were:

  • to compare the ultrasonographic measurement of BWT in women with DO vs women with other urodynamic diagnosis in a very large population.
  • to verify whether the BWT in women with DO can be different in the clinically or urodinamically different forms of DO.

Condition Intervention
Detrusor Overactivity
Other: ultrasonography

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity

Resource links provided by NLM:

Further study details as provided by Università degli Studi dell'Insubria:

Study Start Date: January 2005
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
detrusor overactivity Other: ultrasonography
transvaginal ultrasonography of bladder wall thickness


Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
all women with urinary dysfunction

Inclusion Criteria:

  • All women referred to our Urogynecology Unit from January 2005 to December 2008 for symptoms of OAB, stress urinary incontinence or mixed incontinence and sottoposte a prove urodinamiche complete were included in this prospective study

Exclusion Criteria:

  • The investigators excluded women with documented recurrent urinary tract infections
  • Previous antimuscarinic treatment
  • Previous pelvic surgery
  • Neurological disease
  • Vaginal prolapse > I stage
  • Symptoms or clinical and/or urodynamic signs of voiding dysfunction
  • Patients included in other ongoing clinical trials during the same study period.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01003457

University of Insubria
Varese, Italy, 21100
Sponsors and Collaborators
Università degli Studi dell'Insubria
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT01003457     History of Changes
Other Study ID Numbers: uninsubria1 
Study First Received: October 27, 2009
Last Updated: October 27, 2009
Health Authority: Italy: Ethics Committee processed this record on October 27, 2016